Family Office Of America (FOFA) Return on Sales (2026)
Family Office Of America (FOFA) posted Return on Sales of 0.0% for Q1 2026.
Family Office Of America (FOFA) Return on Sales (2026) Analysis & Trends
Family Office Of America has reported Return on Sales for 1 years, with the latest figure at 0.0% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 0.00% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 0.00% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 0.00% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 0.00% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 0.00% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 0.00% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 0.00% |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |